REPORT ID 5115

United States Artificial Organs Market Report 2017

Publish Date
20-Dec-17
Pages
107
Format
Electronic (PDF)

In this report, the United States Artificial Organs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Artificial Organs in these regions, from 2012 to 2022 (forecast).

United States Artificial Organs market competition by top manufacturers/players, with Artificial Organs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Diabetes Care, Inc.
    Abiomed, Inc. 
    Asahi Kasei Medical Co., Ltd.
    Baxter International, Inc.
    F.Hoffmann-La Roche Ltd. 
    Fresenius Medical Care AG & Co. KGaA 
    HeartWare International, Inc. 
    Jarvik Heart, Inc. 
    Medtronic, Inc. 
    Nikkiso Co., Ltd.
    Nipro Corporation 
    SynCardia Systems, Inc.
    Terumo Heart, Inc. 
    Thoratec Corp.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Artificial Heart
    Artificial Liver
    Artificial Pancreas
    Artificial Lungs
    Artificial Kidney
    Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Artificial Organs Market Report 2017
1 Artificial Organs Overview
    1.1 Product Overview and Scope of Artificial Organs
    1.2 Classification of Artificial Organs by Product Category
        1.2.1 United States Artificial Organs Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Artificial Organs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Artificial Heart
        1.2.4 Artificial Liver
        1.2.5 Artificial Pancreas
        1.2.6 Artificial Lungs
        1.2.7 Artificial Kidney
        1.2.8 Other
    1.3 United States Artificial Organs Market by Application/End Users
        1.3.1 United States Artificial Organs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 United States Artificial Organs Market by Region
        1.4.1 United States Artificial Organs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Artificial Organs Status and Prospect (2012-2022)
        1.4.3 Southwest Artificial Organs Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Artificial Organs Status and Prospect (2012-2022)
        1.4.5 New England Artificial Organs Status and Prospect (2012-2022)
        1.4.6 The South Artificial Organs Status and Prospect (2012-2022)
        1.4.7 The Midwest Artificial Organs Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Artificial Organs (2012-2022)
        1.5.1 United States Artificial Organs Sales and Growth Rate (2012-2022)
        1.5.2 United States Artificial Organs Revenue and Growth Rate (2012-2022)

2 United States Artificial Organs Market Competition by Players/Suppliers
    2.1 United States Artificial Organs Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Artificial Organs Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Artificial Organs Average Price by Players/Suppliers (2012-2017)
    2.4 United States Artificial Organs Market Competitive Situation and Trends
        2.4.1 United States Artificial Organs Market Concentration Rate
        2.4.2 United States Artificial Organs Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Artificial Organs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Artificial Organs Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Artificial Organs Sales and Market Share by Region (2012-2017)
    3.2 United States Artificial Organs Revenue and Market Share by Region (2012-2017)
    3.3 United States Artificial Organs Price by Region (2012-2017)

4 United States Artificial Organs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Artificial Organs Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Artificial Organs Revenue and Market Share by Type (2012-2017)
    4.3 United States Artificial Organs Price by Type (2012-2017)
    4.4 United States Artificial Organs Sales Growth Rate by Type (2012-2017)

5 United States Artificial Organs Sales (Volume) by Application (2012-2017)
    5.1 United States Artificial Organs Sales and Market Share by Application (2012-2017)
    5.2 United States Artificial Organs Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Artificial Organs Players/Suppliers Profiles and Sales Data
    6.1 Abbott Diabetes Care, Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Artificial Organs Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Abbott Diabetes Care, Inc. Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Abiomed, Inc. 
        6.2.2 Artificial Organs Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Abiomed, Inc.  Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Asahi Kasei Medical Co., Ltd.
        6.3.2 Artificial Organs Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Asahi Kasei Medical Co., Ltd. Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Baxter International, Inc.
        6.4.2 Artificial Organs Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Baxter International, Inc. Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 F.Hoffmann-La Roche Ltd. 
        6.5.2 Artificial Organs Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 F.Hoffmann-La Roche Ltd.  Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Fresenius Medical Care AG & Co. KGaA 
        6.6.2 Artificial Organs Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Fresenius Medical Care AG & Co. KGaA  Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 HeartWare International, Inc. 
        6.7.2 Artificial Organs Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 HeartWare International, Inc.  Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Jarvik Heart, Inc. 
        6.8.2 Artificial Organs Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Jarvik Heart, Inc.  Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Medtronic, Inc. 
        6.9.2 Artificial Organs Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Medtronic, Inc.  Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Nikkiso Co., Ltd.
        6.10.2 Artificial Organs Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Nikkiso Co., Ltd. Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Nipro Corporation 
    6.12 SynCardia Systems, Inc.
    6.13 Terumo Heart, Inc. 
    6.14 Thoratec Corp.

7 Artificial Organs Manufacturing Cost Analysis
    7.1 Artificial Organs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Artificial Organs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Artificial Organs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Artificial Organs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Artificial Organs Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Artificial Organs Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Artificial Organs Sales Volume Forecast by Type (2017-2022)
    11.3 United States Artificial Organs Sales Volume Forecast by Application (2017-2022)
    11.4 United States Artificial Organs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer